Skip to content

Based on my review of GO-CAM model 63894f2500001894 and the relevant literature, I will now provide a detailed review of this model.

Review of GO-CAM Model: 63894f2500001894

Model Overview

Title: ARRDC4-mediated activation of MDA5 through K63-ubiquitination by TRIM65 (Human)

Taxon: Human (NCBITaxon:9606)

Status: Production

The model depicts a molecular pathway involving ARRDC4, TRIM65, and MAVS in the regulation of antiviral innate immune response.

Model Evaluation

Biological Content Accuracy

The model accurately represents the findings from the primary reference (PMID:28594402), which demonstrates that ARRDC4 acts as an adaptor protein that interacts with MDA5 and recruits TRIM65 to promote K63-linked ubiquitination of MDA5, enhancing downstream signaling through MAVS.

Key molecular activities captured in the model include: 1. TRIM65's ubiquitin protein ligase activity (GO:0061630) 2. ARRDC4's ubiquitin-like ligase-substrate adaptor activity (GO:1990756) 3. MAVS's signaling adaptor activity (GO:0035591)

The causal relationships are also correctly represented, where: - ARRDC4 directly positively regulates TRIM65 (RO:0002629) - TRIM65 directly positively regulates MAVS (RO:0002629)

Cellular Location Appropriateness

The cellular locations are correctly annotated based on the literature: - TRIM65 activity occurs in the cytoplasm (GO:0005737), supported by PMID:34512673 - ARRDC4 activity is correctly placed in the cytoplasm (GO:0005737) - MAVS activity is correctly placed on the mitochondrial membrane (GO:0031966), supported by PMID:20451243

Evidence and Annotation Quality

The model uses appropriate evidence codes and references: - ECO:0000314 (direct assay evidence used in manual assertion) with PMID references - ECO:0000305 (curator inference used in manual assertion) for the ARRDC4 location

GO-CAM Modeling Best Practices

Based on the GO-CAM modeling guidelines for complexes, this model follows the recommended approach where the specific proteins carrying the activities are known and represented individually rather than using a complex ID.

The causal flow in the model appropriately represents how ARRDC4 acts as an adapter to recruit TRIM65, which then ubiquitinates MDA5, leading to MAVS activation.

Identified Issues

I noted a minor issue in the model related to causal relationships. There appears to be a duplicate causal association:

{
  "type": "CausalAssociation",
  "evidence": [],
  "predicate": "RO:0002629",
  "downstream_activity": "gomodel:63894f2500001894/63894f2500001898"
}

This is a redundant entry without evidence that duplicates another causal relationship between ARRDC4 and TRIM65.

Recommendations

  1. Remove Duplicate Causal Association: The empty evidence causal association between ARRDC4 and TRIM65 should be removed as it's redundant.

  2. Add More Molecular Detail: The model could potentially be enhanced by adding more detailed information about:

  3. The specific lysine residue (K743) on MDA5 that is ubiquitinated by TRIM65, as mentioned in the paper

  4. The specific protein-protein interaction domains involved (e.g., ARRDC4's arrestin-like N domain interacts with MDA5)

  5. Process Annotation: While the model correctly shows that both TRIM65 and ARRDC4 participate in "protein K63-linked ubiquitination" (GO:0070534), it might be valuable to add additional biological process annotations to MAVS, such as "positive regulation of interferon-beta production" (GO:0032728), as this is the downstream outcome of this pathway.

Conclusion

Overall, this GO-CAM model accurately represents the biological pathway described in the primary literature. The model effectively captures the role of ARRDC4 as an adaptor protein that promotes TRIM65-mediated K63-linked ubiquitination of MDA5, leading to MAVS activation and subsequent innate immune response. The model follows GO-CAM best practices for representing molecular activities and their causal relationships.

The model is scientifically sound, with appropriate evidence and references supporting each assertion. The minor issues identified can be easily addressed to improve the model's clarity and completeness.